Public Health - Expedited Partner Therapy - Bacterial Vaginosis and Licensed Certified Midwives
SB 394 adds bacterial vaginosis to Maryland's list of conditions eligible for expedited partner therapy (EPT). This allows certain healthcare providers - like physicians, advanced practice nurses, and pharmaciststo prescribe antibiotics to a sexual partner of a diagnosed patient without requiring a personal examination of the partner. The law aims to prevent reinfection in the diagnosed patient and stop disease spread, expanding existing EPT rules that previously covered only chlamydia, gonorrhea, and trichomoniasis. It applies to public and private health care settings in Maryland starting October 1, 2026.
Bill status
signed
all 5 stages cleared
Introduction
Jan 2026
Committee Review
Apr 2026
Senate Passage
Apr 2026
House of Delegates Passage
Apr 2026
Signed into Law
Apr 2026
Introduced Jan 28, 2026
Signed Apr 28, 2026
Maddy AI version diff · 1 comparison
What changed between versions
First - Public Health - Expedited Partner Therapy - Bacterial Vaginosis
→
Third - Public Health - Expedited Partner Therapy - Bacterial Vaginosis
·
3 edits
MINOR
The bill was amended to expand the scope of Expedited Partner Therapy by adding Licensed Certified Midwives to the list of eligible healthcare providers. This change allows midwives to prescribe antibiotics to sexual partners for bacterial vaginosis without a physical exam, alongside physicians, nurses, and physician assistants.
Scope change
The bill's scope expanded from covering physicians, nurses, and physician assistants to also include licensed certified midwives.
ELIGIBILITY
Added licensed certified midwives to the list of healthcare practitioners authorized to provide expedited partner therapy for bacterial vaginosis.
Revised the list of eligible providers in the statute to include a new category for certified midwives licensed under Title 8, Subtitle 6D.
SCOPE
Updated the bill title and purpose statement to explicitly include licensed certified midwives and bacterial vaginosis.
Floor votes · Senate Feb 18, 2026 · House of Delegates Mar 17, 2026
How they voted
46–0
Passed · 3 other
Total votes 49
Feb 18, 2026
D
Democratic36
94% Yea
R
Republican13
92% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
15
Key actions
10
Committee
6
Apr 28, 2026
Signed into law
Approved by the Governor - Chapter 193
executive
Apr 3, 2026
Upper · Passed
Returned Passed
upper
Apr 2, 2026
Lower · Passed
Third Reading Passed
lower
Apr 1, 2026
Lower · Passed
Favorable Adopted Second Reading Passed
lower
Apr 1, 2026
Lower · Passed
Favorable Report by Health
lower
Mar 17, 2026
House Of Delegates · Passed
House of Delegates Vote: pass (135-0-7)
house of delegates
Feb 27, 2026
Committee
Referred Health
lower
Feb 26, 2026
Upper · Passed
Third Reading Passed
upper
Feb 24, 2026
Upper · Passed
Favorable with Amendments {
upper
Feb 23, 2026
Upper · Passed
Favorable with Amendments Report by Finance
upper
Feb 18, 2026
Senate · Passed
Senate Vote: pass (46-0-3)
senate
Jan 28, 2026
Committee
First Reading Finance
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Dawn Gile
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 394
Scope: MD
Hi! I can help you understand SB 394. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline